Search
for
Sort by
Research 31–60 of 1000+
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Fullerene C<sub>60</sub> with cytoprotective and cytotoxic potential: prospects as a novel treatment agent in Dermatology?
- Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Dermatologic research techniques
- Dermatological symptoms and sexual abuse: a review and case reports
- Prevalence of pediatric alopecia areata among 572,617 dermatology patients
- Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases
- Dermatological effects of <i>Curcuma</i> species: a systematic review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Update dermatologic laser therapy
- Innovative Uses for Zinc in Dermatology
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Nonhuman primate dermatology: a literature review
- Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
- Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth
- The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part II: Clinical Evidence
- HORMONAL THERAPY IN DERMATOLOGY
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Dermatologic manifestations in patients of renal disease on hemodialysis
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Wigs and hairpieces: Evaluating dermatologic issues
- INTERFERONS IN DERMATOLOGY
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Dermatologie care behind bars
- Dermatology in black skin
- Dermatologists’ perceptions on the utility and limitations of teledermatology after examining 55,000 lesions